Abstract--The effects of N-(n-butyl)-l,3-diaminopropane (BDAP) on cell growth and polyamine content were examined in L1210, SV-3T3 and HT-29 cells. In all cases, BDAP was a specific and highly effective inhibitor of spermine synthesis, and spermine levels were greatly suppressed in the presence of 50/LM BDAP. At the same time, there was a parallel increase in spermidine, which equalled or exceeded the fall in spermine so that total polyamine levels were not reduced. Cell growth was not affected in short-term experiments but culture of L1210 cells for 72-144 hr in the presence of BDAP did lead to an effect on growth that was reversed by the addition of spermine. These results suggest that, in the short term, a normal growth rate is maintained by spermidine but that a function or cellular component critically dependent on spermine becomes depleted at longer times. BDAP was a weak inducer of spermidine/spermine-Nl-acetyltransferase and this enzyme may be responsible for excretion or degradation of the inhibitor. The reduction of spermine produced by BDAP led to a substantial increase in the activity of S-adenosylmethionine decarboxylase (AdoMetDC) showing that the repression of this enzyme by spermine is greater than the repression by spermidine. Although higher concentrations were required, BDAP was as effective an inhibitor of spermine synthesis as the mechanism-based inhibitor, S-adenosyl-l,12-diamino-3-thio-9-azadodecane (AdoDATAD), and produced similar decreases in spermine and increases in AdoMetDC. Prior treatment of HT-29 human colon carcinoma cells with BDAP increased the killing by chloroethylating agents but to a much smaller extent than the increase brought about by the DNA repair inhibitor, O6-benzylguanine. The effect of BDAP is likely to be due to an increased interaction of chloroethylating drugs with nuclear DNA in the absence of spermine since BDAP treatment sensitized cells even in the presence of O6-benzylguanine, which prevents repair of these lesions.
Polyamines are ubiquitous cellular components that may be necessary for a variety of cellular functions and are clearly essential for cell growth [ 14] . Specific inhibitors of enzymes in the polyamine biosynthetic pathway are useful for research into the functions of polyamines and are needed for distinguishing the importance of the individual polyamines, putrescine, spermidine and spermine. In addition, inhibitors of ornithine decarboxylase (ODC) § and of Sadenosylmethionine decarboxylase (AdoMetDC) are useful therapeutic agents for a variety of diseases including trypanosomiasis and cancer [3] [4] [5] [6] . Less attention has been given to inhibitors of the aminopropyltransferases capable of blocking either § Abbreviations: ODC, ornithine decarboxylasc, BDAP, N-(n-butyl)-1,3-diaminopropane; AdoMetDC, S-adenosylmethionine decarboxylase; AdoDATO, S-adenosyl-l,8-diamino-3-thiooctane; AdoDATAD, S-adenosyl-l,12-diamino-3-thio-9-azadodecane; SAT, spermidine/spermine-NI-acetyltransferase; BE-3-4-3, N t ,Nt-'-bis(ethyl) -spermine; BCNU, 1,3-bis(2-chloroethyl)-N-nitrosourea; CCNU, 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, Clomesone, 2-chloroethyl(methylsulfonyl)methanesulfonate; and MTI', 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. spermidine synthase or spermine synthase although several potentially useful agents have been described [7] [8] [9] [10] [11] [12] [13] [14] [15] . These include S-adenosyl-l,8-diamino-3-thiooctane (AdoDATO) 17.9, 10] , cyclohexylamine [8, 111 and trans-4-methylcyclohexylamine [11, 12] that inhibit spermidine synthase, and S-adenosyl-1,12-diamino-3-thio-9-azadodecane (AdoDATAD) [13, 14] , N-(n-butyl)-l,3-diaminopropane (BDAP) [15] and N-(3-aminopropyl)cyclohexylamine [12] that have been reported to interfere with spermine synthase.
There is a particular need for more information on the effects of inhibition of spermine synthesis. Although all mammalian cells and many lower eukaryotes contain a discrete spermine synthase and, therefore, have levels of spermine comparable to those of spermine, the physiological value of this enzyme is unclear. Many studies have shown that spermidine is needed for growth and spermidine is essential for continued protein synthesis by virtue of its role as a precursor of hypusine, a post-translational modification of initiation factor eIF-5A essential for its activity [3-6, 16, 17] . Spermidine can be replaced by spermine in many of its actions, and addition of spermine to cells whose growth is blocked by addition of inhibitors of ODC or AdoMetDC restores growth but spermine can give rise to spermidine by virtue of the spermidine/spermine-NI-acetyltransferase (SAT)/polyamine oxidase pathway. Although the binding of the tetramine, spermine, to nucleic acids and presumably other cellular polyanions is stronger than that of the triamine, spermidine [18, 19] , there are, at present, no known unique functions for spermine itself. Detailed, long-term studies with inhibitors of spermine synthase may be needed to answer this question.
A number of polyamine analogs are also being considered as potential antineoplastic agents [3, 4, 20, 21] . Application of these compounds, of which NI,N12-bis(ethyl)spermine (BE-3-4-3) is an example, reduces further normal cellular content dramatically by repressing ODC and AdoMetDC, inducing SAT and causing the excretion of putrescine, spermidine and N-acetylated polyamines from the cell [20] [21] [22] [23] [24] . Loss of spermine is brought about by such analogs but occurs less readily since spermine itself is not excreted and its disposal appears to require the action of SAT [21, 24] . Reduction of the initial spermine content may allow the analogs to be employed more effectively.
In the experiments reported in this paper, we studied the effects of BDAP on polyamine levels and cell growth in a number of mammalian cell lines and compared its effects with those of AdoDATAD. The structures of these compounds are shown in Fig. 1 .
We also examined the effects of BDAP-induced spermine depletion on the sensitivity of tumor cells to certain alkylating agents. It is known that depletion of putrescine and spermidine brought about by treatment with o:-difluoromethylornithine, an ODC inhibitor, renders cells more susceptible to killing by 1,3-bis(2-chloroethyl)-N-nitrosourea (BCNU) [25, 26] . Although the mechanism underlying this effect is not clear, it presumably relates to a change in the content or persistence of the lesions resulting from interaction of the alkylating agent with DNA. We used BDAP to determine whether depletion of spermine may produce a similar type of effect. Cell culture. The source of the cells and the culture conditions have been described previously for HT-29 cells [24] , SV-3T3 cells [27, 28] and L1210 cells [17] .
MATERIALS AND METHODS

Materials. S-Adenosyl-L-
Enzyme assays. AdoMetDC was assayed by measuring the production of 14CO2 from S-adenosyl- [29, 30] . SATwasassayed by determining the conversion of [14C]acetyI-CoA into [14C]acetyl-spermidine as described [24] .
L-[carboxyj4C]methionine
Polyamine and BDAP analysis. Cells were harvested by centrifugation and washed twice with ice-cold phosphate-buffered saline. The washed cell pellet was resuspended in 10% (w/v) trichloroacetic acid, the protein precipitate was removed by centrifugation, and the supernatant was filtered (0.22~m) before reversed-phase HPLC analysis to separate BDAP, putrescine, spermidine, and spermine. Post-column derivatization with o-phthalaldehyde and fluorescence detection was used to quantitate the polyamines [17] . Cell protein was measured by the method of Bradford [31] . Polyamine content was expressed per milligram of total cell protein.
Effects of chloroethylating agents. The effects on killing by alkylating agents were determined by assaying either colony-forming efficiency or cytotoxicity as follows. Cell colony-forming efficiency after treatment with BDAP was determined by plating HT-29 cells at a density of 0.25 x 10 ~ cells/ 25 cm 2 flask. Four hours later BDAP was added to some flasks, and after a further 92 hr, the medium was replaced with fresh medium containing various concentrations of either CCNU or Clomesone for 2 hr at 37 °. The medium was then replaced with the same medium as that used for the pretreatment for an additional 18 hr, and the cells were re-plated at densities between 100 and 3200 per 25 cm 2 flask. The cells were allowed to grow for 10-12 days, and colonies were then washed with 0.9% saline, stained with 0.5% crystal violet in ethanol, and counted. Results were expressed as the percentage of colonies present when no chloroethylating agent was added. Cytotoxicity was evaluated using modifications of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra. zolium bromide (MTT) assay [32] . Cells were plated at a density of 500cells/well in 96-well plates, allowed to grow and treated with chloroethylating agents as described above. Five days after drug treatment, 25/JL of a 5 mg/mL solution of MTT was BDAP was added at 4 hr after plating and the cells were grown for the time shown. BE-3-4-3 was added after 48 hr of culture and the cells were harvested 24 hr later. Results are the means -SD for at least 4 estimations. added to each well followed 2 hr later by the addition of 100/~L lysing buffer, pH 4.7 (20% sodium dodecyl sulfate, 50% N,N-dimethylformamide and 0.8% acetic acid) for an additional 22 hr. A microplate reader set at 570nm was used to determine the absorbance. The number of cells killed was then determined as the fraction of the optical density seen in the cells treated with vehicle alone.
RESULTS
Depletion of spermine by BDAP. Addition of 50 jaM BDAP to the culture medium led to a marked depletion of spermine (by about 80%) within 48-72hr in several different mammalian cell lines, virally transformed mouse fibroblasts (SV-3T3), mouse leukemia cells (L1210) and human colon carcinoma cells (HT-29) (Table 1) . At the same time, there was an increase in cellular spermidine. This is consistent with BDAP blocking the spermine synthase step of polyamine biosynthesis. Because of the compensatory increase in spermidine, there was no decrease in total polyamine content. This total remained the same in L1210 cells, increased slightly in SV-3T3, and increased to a greater extent at 72 hr in HT-29 cells. Exposure to BDAP also markedly reduced the content of putrescine in all three cell lines (Table 1) . Despite the large decrease in spermine, there was no effect of BDAP on growth of these cells over the 72-hr period tested (results not shown).
When cells were treated with BE-3-4-3, there was a profound drop in the concentrations of all of the polyamines, although spermine was affected to the least extent ( Table 1 ). The combination of BDAP with BE-3-4-3 slightly increased the total extent of polyamine depletion and markedly reduced cellular spermine but there was again a parallel increase in spermidine.
A slightly greater effect on spermine levels (85% reduction) was achieved using 100/~M BDAP rather than 50/~M in HT-29 cells for 48 hr (Fig. 2) . The higher level of B DAP was reflected in the intracellular BDAP content which almost doubled with the higher A. E. PECIG and J. K. COWARD Fig. 3 . Spermine-mediated reversal of LI210 cell growth inhibition by BDAP. LI210 cells were seeded at a density of 10~cells/mL and allowed to grow for 72hr in the presence of 50 #M BDAP and/or 5 ¢tM spermine as shown. The cells were then re-seeded at the starting density in the same medium and grown for a further 72 hr. The procedure was then repeated for a third timc. All cultures contained 1 mM aminoguanidine to prevent conversion of the added spermine to toxic oxidation products.
dose. The reduction in spermine was not increased by further exposure to BDAP for up to 120 hr, and it appears that the effects may be slightly less by 120 hr. At this time point, the reduction in spermine was only 50% with 501tM BDAP and 74% with 100/xM. This may be due to the fact that the cellular content of BDAP actually fell slightly with time ( Fig.  2) , and it is possible that the inhibitor was degraded or excreted.
Effects of BDAP on cell growth. Although in short-term experiments of up to 72-hr exposure, there was no effect of BDAP-mediated spermine depletion on cell growth, this may not be the case at longer times. In HT-29 cells treated for 120 hr, growth was reduced by 22% at 50 ~M BDAP and by 30% with 100pM (results not shown). Longer term effects on growth were, therefore, examined more fully in L1210 cells by re-seeding the treated cells into the medium containing 50/~M BDAP so that growth and effects on polyamines could be tested over a period of 220 hr. As shown in Fig. 3 , an inhibitory effect on growth became apparent at times after 144 hr, and this effect was prevented completely by providing 5 #M spermine. Addition of 5 #M spermine to the culture medium also completely overcame the BDAP-mediated depletion of spermine in the cells at 72 hr (results not shown) and at 144 hr (Table 2 ). There was no change in the intracellular level of BDAP when spermine was added ( Table 2) , showing that the reversal of the effect on growth was not due to a change in uptake of the inhibitor, Similar experiments carried out with D-R cells (DFMO-resistant variants of L1210 that have 100 times higher ODC activities and much higher putrescine and slightly higher spermine contents when grown in the absence of DFMO [33] ) showed exactly the same results (not shown).
Induction of sperrnidine/spermine NLacetyltransferase (SAT) by BDAP. Many polyamine analogs have been shown to act as inducers of SAT.
Since SAT activity is linked to the degradation of polyamines and their excretion from the cell, such induction can contribute significantly to the effects of such analogs on cellular polyamine content [21] . However, as shown in Table 3 , BDAP was only weakly active in inducing SAT, giving a 3-to 4-fold increase as opposed to the more than 100-fold rise in activity produced by a powerful inducer such as BE-3-4-3 [20-24[ . It is therefore unlikely that much of the effect of BDAP on polyamines is due to an increase in polyamine acetylation. However, the induction of SAT could play a role in the reduction of BDAP levels at prolonged incubation times (Fig.  2) , since BDAP is a weak substrate for SAT (Pegg AE and Albanese L, unpublished observations). Con~parison qf BDAP with AdoDA TAD. Overall, the results described above are compatible with BDAP being a relatively specific inhibitor of spermine svnthase leading to an increase in spermidine because of its lack of conversion to spermine. These results suggest that BDAP, which is much easier to synthesize than AdoDATAD, may be as effective and specific as an inhibitor of spermine formation. Direct comparisons in L1210 and HT-29 cells suggest that this is indeed the case (Table 4) . The percentage changes in spermine, spermidine and AdoMetDC were indistinguishable when these inhibitors were compared. The only difference was in the content of putrescine, which was reduced more effectively by BDAP. cells to chloroethylating agents. It has been reported by Marton and colleagues [25, 261 that exposure of cells to inhibitors of ODC increases the sensitivity of some tumor cell lines to killing by chloroethy[ating drugs. The effect of depletion of spermine by BDAP and AdoDATAD on the sensitivity of HT-29 cells to these agents was tested by treating the cells for 2hr with either CCNU or Clomesone. After a further 18hr in the presence of the sperminesynthase inhibitors to allow for the conversion of the initial DNA adducts to interstrand cross-links, the cell killing was measured using either a colonyforming assay (Fig. 4) or a cytotoxicity assay (Fig.  5) . Two different assays were used to ensure that the results were not biased by the assay method. Using the colony-forming assay, it was found that BDAP did enhance killing of HT-29 cells by CCNU or by Clomesone and that this could be prevented by providing spermine (Fig. 4) , A limited study with AdoDATAD also showed a similar enhancement of the effects of Clomesone (results not shown), but these experiments were limited by the small amount of drug available and the inhibition of cell plating by the drug itself. The cytotoxicity assays confirmed Results are the means ±--SD for at least 4 estimations. Activity was measured after exposure to the drugs for the time shown. Results are the means --+ SD for at least 4 estimations.
Effect of BDAP on
E]fects of BDAP on the susc~7~tibility of
that there was an increased killing of BDAP-treated cells (Fig. 5) .
HT-29 cells have a high content of O6-alkylguanine -DNA alkyltransferase which strongly protects against chloroethylating drugs by removing initial monoadducts formed in DNA before they rearrange to form lethal cross-links [36, 37] . The alkyltransferase activity can be depleted by use of O ~'-benzylguanine [33] , and such depletion is known to have a very large effect on the killing of HT-29 cells by chloroethylating agents [38, 39] . Therefore, the possible interaction between O6-benzylguanine and BDAP was tested. Treatment with O6-benzylguanine had the expected result, increasing cytotoxicity substantially (Fig. 5) . BDAP increased cell killing to a smaller extent but was effective in the presence or absence of O6-benzylguanine, suggesting that the effects of spermine depletion were not mediated by changes in DNA repair during the period after treatment with the chloroethylating agents (Fig. 5) .
DISCUSSION
BDAP was reported to be a potent inhibitor of spermine synthase in vitro [15] , and the present results using several cell lines confirm that it can be used to prevent spermine production in mammalian cells. Although the three cell types used in the present experiments have very different spermidine to spermine ratios, exposure to BDAP brought about a substantial decline in spermine in all of them. In fact, the 81)% decline in spermine seen in response to BDAP is consistent with an almost complete block at the spermine synthase step. Spermine degradation and excretion occur to only a very limited extent in these cell cultures so the decline in spermine is brought about by the increase in cell number under conditions in which spermine synthesis is prevented.
General problems with biochemical and pharmacological studies using inhibitors include the difficulty in establishing the specificity of the effects and the possible lack of uptake and/or stability of the inhibitors. Since the structure of BDAP is very different from that of the nucleoside spermine synthase inhibitor AdoDATAD [13] (Fig. 1) , the two compounds provide a useful pair to evaluate the effects of spermine. Both inhibitors are clearly superior to other compounds used to block spermine production such as dimethyl(5'-adenosyl)sulfonium salt [27] [28] [29] . The availability of BDAP to complement studies with AdoDATAD should make it easier to establish that effects are due to perturbation of polyamine levels. Also, since BDAP is easier to synthesize than AdoDATAD and is not likely to interact with adenosine receptors, it may be more suitable for long-term studies in intact animals. It should be noted, however, that the results shown in Fig. 2 suggest that the induction of resistance to BDAP may reduce its effectiveness slightly and necessitate higher doses for prolonged exposure. The decreased effectiveness of BDAP at later time points appears to be due to a diminished intracellular level of BDAP but the means by which this reduction is brought about are unclear. One possibility is the induction of SAT by BDAP followed by the acetylation of the compound by this enzyme. SAT activity in mammalian cells is normally very low but can be increased greatly in response to a variety of stimuli including treatment with polyamine analogs [20] [21] [22] [23] [24] . Although BDAP was much less active than BE-3-4-3 as an SAT inducer (Table 3) , activity was increased. The general structural requirement for substrates that can be acetylated by SAT is the presence of an aminopropyl group attached to another N atom [i.e. H2N(CH2)3NH-R ] [21] . BDAP has a suitable structure and is acetylated by SAT, albeit at a rate less than I% that of spermidine (Pegg AE and Albanese L, unpublished observations). In general, acetylation of polyamines leads to further degradation and/or excretion from the cell [21] so the involvement of SAT in reduction of BDAP levels by this mechanism is a plausible hypothesis.
In addition to its effect on spermine levels, exposure to BDAP leads to a substantial increase in AdoMet DC activity. It is well known that AdoMetDC is repressed by both spermidine and spermine [30, 34, 35] . The results with BDAP are in agreement with this concept. Furthermore, they show that spermine is more effective than spermidine in this respect, since there was an increase in spermidine comparable with the decline in spermine in BDAPtreated cells.
The only major difference between the results of exposure to BDAP and to AdoDATAD was that putrescine levels were much lower in cells exposed to BDAP (Table 4 ). The decline in putrescine in response to AdoDATAD may be due to the fact that spermidine is a better repressor of ODC than spermine and/or to the increase in AdoMetDC activity that provides more substrate to convert putrescine into spermidine [3, 4, 30, 35, 40] . However, this can explain only part of the decline in putrescine when BDAP is used since AdoMetDC levels increased and ODC levels declined to the same extent with both AdoDATAD and BDAP (results not shown). The possibility that BDAP and putrescine compete for an uptake system and that BDAP causes an efflux of putrescine from the cell is suggested by these results.
Depletion of spermine by BDAP had no effect on growth in short-term experiments. This is in agreement with several other studies showing that inhibition of spermine synthesis does not influence cell growth [14, 15, [27] [28] [29] [30] , but it is premature to conclude that spermine does not play a vital role in mammalian cellular metabolism. As shown in Fig.  3 , longer term exposures may have more marked effects, and recent results [17] have shown that spermine is more effective than spermidine in reversing the cytostatic effects of inhibitors of AdoMetDC. This cytostasis does not become apparent until 12 days of elimination of AdoMetDC activity [17] .
Although short-term exposures to BDAP had no effect on growth, the compound (and other spermine synthase inhibitors) may be useful in modifying the effects of other agents. First, since spermidine is more readily depleted in cells exposed to polyamine analogs than spermine, the use of a spermine synthase inhibitor may make it easier to deplete polyamines in oivo using analogs such as BE-3-4-3. However, as shown in Table 1 , in cell culture even the analogs alone were effective. Second, in HT-29 tumor cells, exposure to BDAP increased the killing by chloroethylating agents. This effect is likely to result from an increased level of DNA damage rather than a decreased rate of repair since it occurred in the presence of O6-benzylguanine, a drug known to block repair of the initial DNA lesions that then go on to form lethal cross-links [36--39] . The effect of BDAP was reversed by spermine, and it is possible that the change in spermine levels renders some sites in chromatin more available to interact with the drugs. This suggests that spermine depletion may be useful as treatment with ODC inhibitors [25] in increasing the effects of chloroethylating agents. However, it should be cautioned that this effect may be dependent on the tumor cell type involved. HT-29 cells have very high levels of spermine and a high spermine:spermidine ratio (Table 1) , and this may influence their response to such drug combinations.
